GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the Apotheke rule is doing its job and people should stop complaining — 68 comments in the full submission. View in context.
2.3k
c/glp1eu·submitted 1 year ago by u/meera_oyelaran

[Meta] the Apotheke rule is doing its job and people should stop complaining

Pricingbranch of 9 comments

the Apotheke rule is doing its job and people should stop complaining — posting the reasoning in public because a policy you cannot inspect is just a preference. Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to…

Read the full submission and all 68 comments →

This branch

9 comments, started 1 year ago
u/zaid_eriksen33 points·1 year ago

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

replysharereportpermalink
u/jarno_karlsen24 points·1 year ago

The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.

replysharereportpermalink
u/marisol_frisk6 points·1 year ago

Kept the prescription and the receipt for a claim, purely because a thread here told me to. Both were requested.

replysharereportpermalink
u/arne_ndiaye0 points·1 year ago

cross-border prescription rules exist and they are narrower than people think

replysharereportpermalink
u/preservative_free_p3 points·1 year ago

What does the local patient information leaflet say?

replysharereportpermalink
u/marit_laurent1 point·1 year ago

say which country or the thread is useless

replysharereportpermalink
u/fabio_nkemelu21 points·1 year ago

the EMA authorises, member states decide who pays

replysharereportpermalink
u/tobias_vukovic13 points·1 year ago

Reimbursed or private?

replysharereportpermalink
u/eu_apotheke_a9 points·1 year ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.